Carol Ashe

Carol Ashe

Directeur/Membre du Conseil chez ELICIO THERAPEUTICS, INC.

Fortune : - $ au 31/05/2026

68 ans
Health Technology
Consumer Services
Finance

Profil

Carol G.
Ashe
currently works at Elicio Therapeutics, Inc. (United States), as Independent Director from 2020, Elicio Therapeutics, Inc., as Independent Director from 2020, and New York Genome Center, as Chief Business Officer from 2014.
Ms. Ashe also formerly worked at Aptose Biosciences, Inc., as Independent Director from 2018 to 2025, Endo International Plc, as Vice President-Corporate Development from 2011 to 2013, GSK Equity Investments Ltd, as Partner from 2009 to 2010, and GSK Plc, as Head-US Corporate Legal Group from 2007 to 2008.
Ms. Ashe received her undergraduate degree from The Pennsylvania State University and graduate degree from Villanova University School of Law.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
09/04/2026 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Carol Ashe

SociétésPosteDébut
ELICIO THERAPEUTICS, INC. Directeur/Membre du Conseil 01/08/2020
Corporate Officer/Principal 01/01/2014
Directeur/Membre du Conseil 01/01/2020

Anciens postes connus de Carol Ashe

SociétésPosteFin
APTOSE BIOSCIENCES INC. Directeur/Membre du Conseil 16/06/2025
ENDO INTERNATIONAL PLC Corporate Officer/Principal 01/01/2013
Private Equity Investor 30/03/2010
GSK PLC Corporate Officer/Principal 01/01/2008
Voir l'expérience en détail de Carol Ashe

Formation de Carol Ashe

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

79

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. Carol Ashe
🔇